Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers
Clinical trial NCT00798252 · COMPLETED
Trial details
- NCT number
- NCT00798252
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2015-05-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.